FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1709985587> ?p ?o ?g. }

• W1709985587 endingPage "373" @default.
• W1709985587 startingPage "366" @default.
• W1709985587 abstract "Little is known about the clinical benefit of a non-vitamin K antagonist oral anticoagulant compared with warfarin in elderly Chinese patients with atrial fibrillation (AF).The purpose of this study was to evaluate the clinical benefit of dabigatran in elderly (age ≥80 years) Chinese patients with nonvalvular AF with regard to the risk of ischemic stroke and intracranial hemorrhage (ICH).This was an observational study.We studied 571 Chinese patients (mean age 84.8 ± 4.0 years; 58.1% women) with nonvalvular AF. The primary outcome was hospital admission for ischemic stroke, and the secondary outcome was admission for ICH. The mean CHA2DS2-VASc (congestive heart failure [1 point], hypertension [1 point], age 65-74 years [1 point] and age ≥75 years [2 points], diabetes mellitus [1 point], prior stroke or transient ischemic attack [2 points], vascular disease [1 point], sex category [female] [1 point]) and HAS-BLED (hypertension [1 point], abnormal renal/liver function [1 point], stroke [1 point], bleeding history [1 point] or predisposition [1 point], labile international normalized ratio [1 point], elderly [age >65 years] [1 point], drugs/alcohol concomitantly [1 point]) scores were 4.8 ± 1.6 and 2.4 ± 0.8, respectively. Of 571 patients, 129 (22.6%) were taking dabigatran 110 mg twice daily and the remaining were on warfarin. After a mean follow-up of 2.6 years (a total of 1471 patient-years), ischemic stroke occurred in 83 patients on warfarin (6.9% per year) compared with 4 patients on dabigatran (1.4% per year) (hazard ratio 0.22; 95% confidence interval 0.23-0.67). There were 8 incidences of ICH: 7 in patients on warfarin (0.59% per year) and 1 patient on dabigatran (0.35% per year). Dabigatran was associated with a substantially lower ischemic stroke risk (1.4% per year vs 5.4% per year) and similar ICH risk (0.35% per year vs 0.36% per year) as compared with warfarin with time in therapeutic range (TTR) ≥55%.In elderly Chinese patients with AF, this study suggested that dabigatran achieved superior stroke risk reduction and similar risk of ICH compared with warfarin with TTR ≥55%. Dabigatran may be preferable to warfarin in elderly patients with AF for stroke prevention, particularly in those with poor TTR." @default.
• W1709985587 created "2016-06-24" @default.
• W1709985587 creator A5016357043 @default.
• W1709985587 creator A5017685479 @default.
• W1709985587 creator A5024458306 @default.
• W1709985587 creator A5025840041 @default.
• W1709985587 creator A5036128689 @default.
• W1709985587 creator A5036658441 @default.
• W1709985587 creator A5037752753 @default.
• W1709985587 creator A5045095539 @default.
• W1709985587 creator A5051609622 @default.
• W1709985587 creator A5079729727 @default.
• W1709985587 creator A5082409466 @default.
• W1709985587 creator A5089549147 @default.
• W1709985587 date "2016-02-01" @default.
• W1709985587 modified "2023-10-01" @default.
• W1709985587 title "Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation" @default.
• W1709985587 cites W1132187882 @default.
• W1709985587 cites W1547546593 @default.
• W1709985587 cites W1586488555 @default.
• W1709985587 cites W1975650244 @default.
• W1709985587 cites W1983220190 @default.
• W1709985587 cites W1999468381 @default.
• W1709985587 cites W2004756207 @default.
• W1709985587 cites W2007208050 @default.
• W1709985587 cites W2009585207 @default.
• W1709985587 cites W2011392575 @default.
• W1709985587 cites W2014960856 @default.
• W1709985587 cites W2017208646 @default.
• W1709985587 cites W2026219040 @default.
• W1709985587 cites W2031990245 @default.
• W1709985587 cites W2066238141 @default.
• W1709985587 cites W2072561903 @default.
• W1709985587 cites W2073374695 @default.
• W1709985587 cites W2078795472 @default.
• W1709985587 cites W2085975373 @default.
• W1709985587 cites W2087874672 @default.
• W1709985587 cites W2096570004 @default.
• W1709985587 cites W2097854437 @default.
• W1709985587 cites W2104416405 @default.
• W1709985587 cites W2113865206 @default.
• W1709985587 cites W2124601103 @default.
• W1709985587 cites W2127985968 @default.
• W1709985587 cites W2133435868 @default.
• W1709985587 cites W2136489990 @default.
• W1709985587 cites W2138097413 @default.
• W1709985587 cites W2159730165 @default.
• W1709985587 cites W2162508946 @default.
• W1709985587 cites W2162586165 @default.
• W1709985587 cites W2165762371 @default.
• W1709985587 cites W2171165037 @default.
• W1709985587 cites W3030533492 @default.
• W1709985587 cites W4211201645 @default.
• W1709985587 doi "https://doi.org/10.1016/j.hrthm.2015.09.015" @default.
• W1709985587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26392326" @default.
• W1709985587 hasPublicationYear "2016" @default.
• W1709985587 type Work @default.
• W1709985587 sameAs 1709985587 @default.
• W1709985587 citedByCount "33" @default.
• W1709985587 countsByYear W17099855872016 @default.
• W1709985587 countsByYear W17099855872017 @default.
• W1709985587 countsByYear W17099855872018 @default.
• W1709985587 countsByYear W17099855872019 @default.
• W1709985587 countsByYear W17099855872020 @default.
• W1709985587 countsByYear W17099855872021 @default.
• W1709985587 countsByYear W17099855872022 @default.
• W1709985587 crossrefType "journal-article" @default.
• W1709985587 hasAuthorship W1709985587A5016357043 @default.
• W1709985587 hasAuthorship W1709985587A5017685479 @default.
• W1709985587 hasAuthorship W1709985587A5024458306 @default.
• W1709985587 hasAuthorship W1709985587A5025840041 @default.
• W1709985587 hasAuthorship W1709985587A5036128689 @default.
• W1709985587 hasAuthorship W1709985587A5036658441 @default.
• W1709985587 hasAuthorship W1709985587A5037752753 @default.
• W1709985587 hasAuthorship W1709985587A5045095539 @default.
• W1709985587 hasAuthorship W1709985587A5051609622 @default.
• W1709985587 hasAuthorship W1709985587A5079729727 @default.
• W1709985587 hasAuthorship W1709985587A5082409466 @default.
• W1709985587 hasAuthorship W1709985587A5089549147 @default.
• W1709985587 hasConcept C126322002 @default.
• W1709985587 hasConcept C127413603 @default.
• W1709985587 hasConcept C134018914 @default.
• W1709985587 hasConcept C164705383 @default.
• W1709985587 hasConcept C207103383 @default.
• W1709985587 hasConcept C2776301958 @default.
• W1709985587 hasConcept C2778198053 @default.
• W1709985587 hasConcept C2778810321 @default.
• W1709985587 hasConcept C2779161974 @default.
• W1709985587 hasConcept C2780645631 @default.
• W1709985587 hasConcept C44249647 @default.
• W1709985587 hasConcept C555293320 @default.
• W1709985587 hasConcept C71924100 @default.
• W1709985587 hasConcept C78519656 @default.
• W1709985587 hasConceptScore W1709985587C126322002 @default.
• W1709985587 hasConceptScore W1709985587C127413603 @default.
• W1709985587 hasConceptScore W1709985587C134018914 @default.
• W1709985587 hasConceptScore W1709985587C164705383 @default.
• W1709985587 hasConceptScore W1709985587C207103383 @default.

• next